Cardiotoxicity of Immune Checkpoint Inhibitors

Dorte Lisbet Nielsen,Carsten Bogh Juhl,Ole Haagen Nielsen,Inna Markovna Chen,Joerg Herrmann
DOI: https://doi.org/10.1001/jamaoncol.2024.3065
IF: 33.006
2024-10-19
JAMA Oncology
Abstract:This systematic review and meta-analysis updates data on the incidence of cardiovascular adverse events in clinical trials of immune checkpoint inhibitors alone and in combination therapies and provides recommendations for management among patients treated for cancer.
oncology
What problem does this paper attempt to address?